Stockscreener 앱 받기
6.63
2.07%
-0.14
시장 영업 전:
6.78
0.15
+2.26%
Optimizerx Corp 주식(OPRX)의 최신 뉴스
Earnings preview: OptimizeRx Corp. (OPRX) Q1 earnings expected to decline - MSN
OptimizeRx (OPRX) Projected to Post Earnings on Tuesday - MarketBeat
Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline - Yahoo Finance
Are Investors Undervaluing OptimizeRx (OPRX) Right Now? - Yahoo Finance
OptimizeRx (OPRX) price target decreased by 40.41% to 14.79 - MSN
OPRX Technical Analysis & Stock Price Forecast - Intellectia AI
OPRX SEC FilingsOptimizerx Corp 10-K, 10-Q, 8-K Forms - Stock Titan
[ARS] OptimizeRx Corp SEC Filing - Stock Titan
OptimizeRx (OPRX) sets 2026 virtual meeting, equity plan expansion and pay votes - Stock Titan
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report - marketscreener.com
OptimizeRx (OPRX) soars 5.9%: Is further upside left in the stock? - MSN
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET - The Manila Times
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4: 30 p.m. ET - marketscreener.com
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 P.m. ET - Moomoo
OPRX OptimizeRx Corporation posts 120.6 percent Q4 2025 EPS surprise, shares rise modestly in today’s trading. - Newser
OptimizeRx (OPRX) Price Target Increased by 24.79% to 24.82 - MSN
OptimizeRx vs. GoodRx: Which Digital Health Stock is the Better Buy? - TradingView
JMP Securities Maintains OptimizeRx (OPRX) Market Outperform Recommendation - MSN
Will Enterprise Deals & MedTech Momentum Fuel OPRX's Growth Engine? - TradingView
OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
New OptimizeRx Corp (OPRX) director registers insider status with Form 3 - Stock Titan
Can OptimizeRx's Cash Strength Cushion Near-Term Headwinds? - Yahoo Finance
OptimizeRx Corporation (OPRX) Stock Hits 52-Week High (Weakens) 2026-04-20Institutional Buying - Newser
How The OptimizeRx (OPRX) Narrative Is Shifting As Revenue Caution Meets Profit Optimism - Yahoo Finance
OPRX Trades at a Discount to Industry: How to Approach the Stock Now? - TradingView
Should Value Investors Buy OptimizeRx (OPRX) Stock? - Yahoo Finance
Medical robotics firm Myomo taps ex-OptimizeRx chief for board seat - Stock Titan
OptimizeRx Corp. (NASDAQ:OPRX) Sees Significant Growth in Short Interest - MarketBeat
OPRX Cuts Revenue Outlook: Temporary Reset or Structural Concern? - qz.com
If You Invested $1,000 in Optimizerx Corp (OPRX) - Stock Titan
Whats the profit margin of OptimizeRx Corporation2026 Price Targets & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
OptimizeRx Corp. Receives Favorable Valuation Adjustment Amidst Profit Growth and High Institutional Confidence - Markets Mojo
OptimizeRx Adds Microsoft Health Leader to Board - TipRanks
OptimizeRx adds Microsoft Health exec to board of directors By Investing.com - Investing.com Australia
OptimizeRx adds Microsoft Health exec to board of directors - Investing.com
Microsoft health leader joins OptimizeRx (OPRX) board as independent director - Stock Titan
OptimizeRx Appoints Microsoft Health & Life Sciences COO to Board - National Today
OptimizeRx Appoints Mary Varghese Presti to Board of Directors - Bitget
OptimizeRx Taps Microsoft AI Leader for Board to Supercharge Growth - BriefGlance
List of 3 Acquisitions by OptimizeRx (Apr 2026) - Tracxn
Best Value Stocks to Buy for March 16th - Eastern Progress
What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now? - MSN
1.66%
1.60%
자본화:
|
볼륨(24시간):